Platelet-induced thrombin generation by the calibrated automated thrombogram assay is increased in patients with essential thrombocythemia and polycythemia vera

Nitric oxide derivatives and soluble plasma selectins in patients with myeloproliferative neoplasms

(2010) Giuseppe Cella et al.   THROMBOSIS AND HAEMOSTASIS

Functional regulation of vascular and platelet activity during thrombosis by nitric oxide and endothelial nitric oxide synthase

(2010) Christopher Moore et al.   THROMBOSIS AND HAEMOSTASIS

Residual platelet factor V ensures thrombin generation in patients with severe congenital factor V deficiency and mild bleeding symptoms

(2009) C. Duckers et al.   BLOOD

Association of V617F Jak2 mutation with the risk of thrombosis among patients with essential thrombocythaemia or idiopathic myelofibrosis: A systematic review

(2009) Federico Lussana et al.   THROMBOSIS RESEARCH

Detection of endogenous tissue factor levels in plasma using the calibrated automated thrombogram assay

(2009) Veronique Ollivier et al.   THROMBOSIS RESEARCH

Platelet turnover, coagulation factors, and soluble markers of platelet and endothelial activation in essential thrombocythemia: Relationship with thrombosis occurrence andJAK2 V617F allele burden

(2008) Eduardo Arellano-Rodrigo et al.   AMERICAN JOURNAL OF HEMATOLOGY

Thrombin generation and activated protein C resistance in patients with essential thrombocythemia and polycythemia vera

(2008) M. Marchetti et al.   BLOOD

TheJAK2V617Fmutation and thrombosis

(2008) S. K. Austin et al.   BRITISH JOURNAL OF HAEMATOLOGY

Rapid decline of JAK2V617F levels during hydroxyurea treatment in patients with polycythemia vera and essential thrombocythemia

(2008) A. Ricksten et al.   HAEMATOLOGICA

Evidence and expertise in the management of polycythemia vera and essential thrombocythemia

(2008) G Finazzi et al.   LEUKEMIA